scholarly journals Comparison of Radiologist-Assigned Categories and Quantitative Measures of Background Parenchymal Enhancement on Breast MRI

Author(s):  
Bethany L Niell ◽  
Mahmoud Abdalah ◽  
Olya Stringfield ◽  
Malesa Pereira ◽  
Dana Ataya ◽  
...  

AbstractBackground parenchymal enhancement (BPE) on multi-parametric breast magnetic resonance imaging (mpMRI) reflects the volume and intensity of gadolinium uptake. We developed a semi-automated segmentation algorithm to extract and quantify measures of BPE and investigated the agreement of computed measures of BPE with radiologist-assigned categories. We retrospectively identified 123 high risk patients with breast mpMRI performed for screening indications. Pre- and post-gadolinium T1-weighted series with and without fat suppression were co-registered. Using Otsu’s method and an active contours method, the breast tissue was segmented from the chest wall and non-fat voxels were clustered to identify the amount of fibroglandular tissue. Median and inter-quartile ranges for the absolute volume of BPE (BPE cm3) and the percentage of BPE (BPE%) using a threshold PE of 30% were computed within the segmented FGT on the first post-contrast phase. Student’s t-test was used to evaluate BPE volume and BPE% by radiologist-assigned categories. Both BPE volume and BPE% differed significantly between minimal/mild and moderate/marked radiologist assigned categories (p=0.030 and 0.004, respectively). Using our newly developed semi-automated segmentation pipeline, we quantified fibroglandular tissue and BPE. The overlapping ranges of quantitative BPE corresponding to the radiologist-assigned BPE categories showcases the inter-reader variability with visual estimation of BPE.

2012 ◽  
Vol 22 (12) ◽  
pp. 2641-2647 ◽  
Author(s):  
Valencia King ◽  
Yajia Gu ◽  
Jennifer B. Kaplan ◽  
Jennifer D. Brooks ◽  
Malcolm C. Pike ◽  
...  

2018 ◽  
Vol 60 (1) ◽  
pp. 19-27 ◽  
Author(s):  
Paola Clauser ◽  
Matthias Dietzel ◽  
Michael Weber ◽  
Clemens G Kaiser ◽  
Pascal AT Baltzer

Background Motion artifacts can reduce image quality of breast magnetic resonance imaging (MRI). There is a lack of data regarding their effect on diagnostic estimates. Purpose To evaluate factors that potentially influence readers’ diagnostic estimates in breast MRI: motion artifacts; amount of fibroglandular tissue; background parenchymal enhancement; lesion size; and lesion type. Material and Methods This Institutional Review Board-approved, retrospective, cross-sectional, single-center study included 320 patients (mean age = 55.1 years) with 334 histologically verified breast lesions (139 benign, 195 malignant) who underwent breast MRI. Two expert breast radiologists evaluated the images considering: motion artifacts (1 = minimal to 4 = marked); fibroglandular tissue (BI-RADS FGT); background parenchymal enhancement (BI-RADS BPE); lesion size; lesion type; and BI-RADS score. Univariate (Chi-square) and multivariate (Generalized Estimation Equations [GEE]) statistics were used to identify factors influencing sensitivity, specificity, and accuracy. Results Lesions were: 230 mass (68.9%) and 59 non-mass (17.7%), no foci. Forty-five lesions (13.5%) did not enhance in MRI but were suspicious or unclear in conventional imaging. Sensitivity, specificity, and accuracy were 93.8%, 83.4%, and 89.8% for Reader 1 and 95.4%, 87.8%, and 91.9% for Reader 2. Lower sensitivity was observed in case of increased motion artifacts ( P = 0.007), non-mass lesions ( P < 0.001), and small lesions ≤ 10 mm ( P < 0.021). No further factors (e.g. BPE, FGT) significantly influenced diagnostic estimates. At multivariate analysis, lesion type and size were retained as independent factors influencing the diagnostic performance ( P < 0.033). Conclusion Motion artifacts can impair lesion characterization with breast MRI, but lesion type and small size have the strongest influence on diagnostic estimates.


2013 ◽  
Vol 24 (1) ◽  
pp. 162-168 ◽  
Author(s):  
E. R. Price ◽  
J. D. Brooks ◽  
E. J. Watson ◽  
S. B. Brennan ◽  
E. A. Comen ◽  
...  

2021 ◽  
Vol 10 ◽  
Author(s):  
Michelle Zhang ◽  
Meredith Sadinski ◽  
Dana Haddad ◽  
Min Sun Bae ◽  
Danny Martinez ◽  
...  

PurposeBreast MRI background parenchymal enhancement (BPE) can potentially serve as a prognostic marker, by possible correlation with molecular subtype. Oncotype Dx, a gene assay, is a prognostic and predictive surrogate for tumor aggressiveness and treatment response. The purpose of this study was to investigate the association between contralateral non-tumor breast magnetic resonance imaging (MRI) background parenchymal enhancement and tumor oncotype score.MethodsIn this retrospective study, patients with ER+ and HER2− early stage invasive ductal carcinoma who underwent preoperative breast MRI, oncotype risk scoring, and breast conservation surgery from 2008–2010 were identified. After registration, BPE from the pre and three post-contrast phases was automatically extracted using a k-means clustering algorithm. Four metrics were calculated: initial enhancement (IE) relative to the pre-contrast signal, late enhancement, overall enhancement (OE), and area under the enhancement curve (AUC). Histogram analysis was performed to determine first order metrics which were compared to oncotype risk score groups using Mann–Whitney tests and Spearman rank correlation analysis.ResultsThis study included 80 women (mean age = 51.1 ± 10.3 years); 46 women were categorized as low risk (≤17) and 34 women were categorized as intermediate/high risk (≥18) according to Oncotype Dx. For the mean of the top 10% pixels, significant differences were noted for IE (p = 0.032), OE (p = 0.049), and AUC (p = 0.044). Using the risk score as a continuous variable, correlation analysis revealed a weak but significant correlation with the mean of the top 10% pixels for IE (r = 0.26, p = 0.02), OE (r = 0.25, p = 0.02), and AUC (r = 0.27, p = 0.02).ConclusionBPE metrics of enhancement in the non-tumor breast are associated with tumor Oncotype Dx recurrence score, suggesting that the breast microenvironment may relate to likelihood of recurrence and magnitude of chemotherapy benefit.


Sign in / Sign up

Export Citation Format

Share Document